ACROBIOSYSTEMS CO., LTD

北京百普赛斯生物科技股份有限公司

Develops, produces and sells biological reagents—recombinant proteins, antibodies and analytical assay kits—plus technical services supporting biopharmaceutical R&D in China and globally. Per Frost & Sullivan, ranked third globally in recombinant proteins with a 2.7% revenue share in 2025.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Social insurance & housing fund
• Litigation & arbitration
• Third-party payments, personal accounts & cash
• Customer concentration
• Supplier concentration
• Distribution model
• Raw material and commodity prices
• Pricing policy and price changes
• Overseas markets and operations
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Investments and fair-value assets
• Transfer pricing
• Non-recurring gains and losses
• Related-party transactions and balances
• Material share-based payments
• Sanctioned countries and export controls